Šárka Bendová

590 total citations
8 papers, 114 citations indexed

About

Šárka Bendová is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Šárka Bendová has authored 8 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Šárka Bendová's work include Neurofibromatosis and Schwannoma Cases (3 papers), Genomics and Rare Diseases (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Šárka Bendová is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (3 papers), Genomics and Rare Diseases (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). Šárka Bendová collaborates with scholars based in Czechia, Sweden and Armenia. Šárka Bendová's co-authors include Zdeněk Sedláček, B. Petrák, Markéta Havlovičová, Roman Kodet, Anna Křepelová, David Sumerauer, Pavlína Plevová, Julie Fleitz, Nicholas K. Foreman and Marie Trková and has published in prestigious journals such as European Journal of Cancer, Journal of Molecular Neuroscience and American Journal of Medical Genetics Part A.

In The Last Decade

Šárka Bendová

7 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Šárka Bendová Czechia 4 53 37 30 26 24 8 114
C. Schaap Netherlands 6 61 1.2× 88 2.4× 29 1.0× 21 0.8× 12 0.5× 8 189
Harry Lesmana United States 7 35 0.7× 26 0.7× 17 0.6× 8 0.3× 13 0.5× 23 107
Ingrid Cristian United States 5 170 3.2× 53 1.4× 39 1.3× 15 0.6× 7 0.3× 5 213
Justin M. Craig United States 6 78 1.5× 10 0.3× 35 1.2× 37 1.4× 61 2.5× 7 147
Constance Wells France 7 49 0.9× 61 1.6× 13 0.4× 3 0.1× 20 0.8× 11 124
P. Hofmann Germany 6 38 0.7× 15 0.4× 9 0.3× 13 0.5× 10 0.4× 13 117
Todd Ackley United States 7 107 2.0× 80 2.2× 67 2.2× 4 0.2× 11 0.5× 10 207
M. J. Grégoire France 7 232 4.4× 92 2.5× 36 1.2× 10 0.4× 11 0.5× 14 302
Colleen Macmurdo United States 4 84 1.6× 73 2.0× 27 0.9× 40 1.5× 24 1.0× 9 183
Maria Lane United States 5 42 0.8× 13 0.4× 64 2.1× 29 1.1× 6 0.3× 8 108

Countries citing papers authored by Šárka Bendová

Since Specialization
Citations

This map shows the geographic impact of Šárka Bendová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Šárka Bendová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Šárka Bendová more than expected).

Fields of papers citing papers by Šárka Bendová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Šárka Bendová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Šárka Bendová. The network helps show where Šárka Bendová may publish in the future.

Co-authorship network of co-authors of Šárka Bendová

This figure shows the co-authorship network connecting the top 25 collaborators of Šárka Bendová. A scholar is included among the top collaborators of Šárka Bendová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Šárka Bendová. Šárka Bendová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Vlčková, Markéta, Darina Prchalová, Jana Haberlová, et al.. (2023). A new patient with congenital myasthenic syndrome type 20 due to compound heterozygous missense SLC5A7 variants suggests trends in genotype–phenotype correlation. Molecular Genetics & Genomic Medicine. 11(6). e2154–e2154. 1 indexed citations
2.
Hančárová, Miroslava, Davit Babikyan, Šárka Bendová, et al.. (2019). A novel variant of C12orf4 in a consanguineous Armenian family confirms the etiology of autosomal recessive intellectual disability type 66 with delineation of the phenotype. Molecular Genetics & Genomic Medicine. 7(9). e865–e865. 4 indexed citations
3.
Šnajderová, Marta, Vincent M. Riccardi, B. Petrák, et al.. (2012). The importance of advanced parental age in the origin of neurofibromatosis type 1. American Journal of Medical Genetics Part A. 158A(3). 519–523. 15 indexed citations
4.
Bendová, Šárka, et al.. (2009). The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Cancer Genetics and Cytogenetics. 193(1). 63–66. 3 indexed citations
5.
Bendová, Šárka, et al.. (2007). Novel mutations in the NF1 gene in Czech patients with neurofibromatosis type 1. Journal of Molecular Neuroscience. 31(3). 273–279. 3 indexed citations
6.
Petrák, B., et al.. (2007). Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1.. PubMed. 28(6). 734–8.
7.
Havlovičová, Markéta, et al.. (2006). A girl with neurofibromatosis type 1, atypical autism and mosaic ring chromosome 17. American Journal of Medical Genetics Part A. 143A(1). 76–81. 34 indexed citations
8.
Trková, Marie, Julie Fleitz, Anna Křepelová, et al.. (2005). Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. European Journal of Cancer. 41(11). 1597–1603. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026